Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

ヒトヘルペスウイルスの8つの変種

N Regamey, P Erb, M Tamm

    Lancet (London, England)
    |March 21, 1998
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    Cystic fibrosis newborn screening in Switzerland - evaluation and scenarios for improvement after 11 years of follow-up.

    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2024
    Same author

    Telehealth mitigates COPD disease progression compared to standard of care: a randomized controlled crossover trial.

    Journal of internal medicine·2021
    Same author

    Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future.

    ESMO open·2021
    Same author

    [Guidelines for the Management of Community Acquired Pneumonia in Children and Adolescents (Pediatric Community Acquired Pneumonia, pCAP) - Issued under the Responsibility of the German Society for Pediatric Infectious Diseases (DGPI) and the German Society for Pediatric Pulmonology (GPP)].

    Pneumologie (Stuttgart, Germany)·2020
    Same author

    [Clinical autopsies in Switzerland : A status report].

    Der Pathologe·2017
    Same author

    Endometrioid endometrial adenocarcinoma: an increase of G3 cancers?

    Archives of gynecology and obstetrics·2017
    Same journal

    Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

    Lancet (London, England)·2026
    Same journal

    Efficacy and safety of tirofiban after successful endovascular reperfusion in acute ischaemic stroke (ATTRACTION) in China: a multicentre, double-blind, randomised controlled trial.

    Lancet (London, England)·2026
    関連記事をすべて見る